Evidence map›Paper›PMID 42297351›Full record

ArticleActa anaesthesiologica Scandinavica2026

General Anaesthesia Versus Spinal Anaesthesia for Outpatient Total Hip and Knee Arthroplasty: A Randomised Trial Protocol.

Erik Noppa, Karuna Dahlberg, Alex de Leon, Maziar Mohaddes, Anna Philipson, Peter Wildeman, Kristofer F Nilsson

Registry-linked trialAbstract readClinical Trial Protocol
In one paragraph

Article in Acta anaesthesiologica Scandinavica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07334132 (General Anaesthesia vs Spinal Anaesthesia), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07334132 phase4not yet recruitingnot on this map

General Anaesthesia vs Spinal Anaesthesia: Patient Outcomes and Success in Outpatient Primary Total Knee and Hip Arthroplasty

TypeinterventionalSponsorRegion Örebro CountyRan2026 to 2029Enrolled600ConditionsOsteo Arthritis Knee and Hip, Osteo Arthritis, Inflammatory Joint Disease (IJD)ArmsGeneral Anaesthesia, Spinal Anesthesia (bupivacaine)
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Erik NoppaSchool of Medical Sciences, Örebro University, Örebro, Sweden.ORCID https://orcid.org/0009-0000-1740-7091
Karuna DahlbergSchool of Health Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.ORCID https://orcid.org/0000-0002-4170-6451
Alex de LeonSchool of Medical Sciences, Örebro University, Örebro, Sweden.
Maziar MohaddesDepartment of Orthopaedics, Institute of Clinical Science, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Anna PhilipsonUniversity Health Care Research Center, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.ORCID https://orcid.org/0000-0001-8433-6529
Peter WildemanSchool of Medical Sciences, Örebro University, Örebro, Sweden.ORCID https://orcid.org/0000-0001-7840-8979
Kristofer F NilssonSchool of Medical Sciences, Örebro University, Örebro, Sweden.ORCID https://orcid.org/0000-0002-8461-5074

Funding

Region Örebro County OLL-1010516Region Örebro County OLL-993657
6 · The paper itself

Abstract

introductionSame-day discharge after primary total hip arthroplasty (THA) and total knee arthroplasty (TKA) is increasing, but the optimal anaesthetic technique for outpatient pathways remains uncertain. Neuraxial anaesthesia is widely recommended based on observational evidence, whereas fast-track programmes using short-acting total intravenous anaesthesia may facilitate early mobilisation and discharge. No randomised controlled trial has compared general anaesthesia (GA) with spinal anaesthesia (SA) specifically in outpatient primary THA/TKA using a same-day discharge target. METHODS AND ANALYSIS: GASPS is a pragmatic, multicentre, parallel-group superiority randomised controlled trial. Adults scheduled for outpatient primary THA or TKA will be randomised 1:1 to GA or SA, with stratification by site and procedure (THA/TKA). The primary outcome is successful same-day discharge (discharge on the day of surgery) without readmission within 48 h after discharge. The five key secondary outcomes are time to fulfilment of hospital discharge indicators, quality-of-recovery (QoR-15) trajectories over postoperative Days 1-35, patients' qualitative experiences of anaesthesia and recovery, cost per quality-adjusted life-year and safety (adverse events); all remaining outcomes-including pain, postoperative nausea and vomiting, opioid consumption, mobilisation and patient-reported outcomes (EQ-5D-5L and HOOS/KOOS)-are exploratory. An embedded qualitative study will explore patient experiences using semi-structured interviews, and an economic evaluation will compare costs and outcomes from healthcare and societal perspectives. Analyses will follow the intention-to-treat principle; a group sequential design with O'Brien-Fleming boundaries is planned for an interim analysis. Approval has been obtained from the Swedish Medical Products Agency. Written informed consent will be obtained from all participants. Results will be disseminated through peer-reviewed publications, conference presentations and reporting in the EU Clinical Trials Information System (CTIS).

conclusionThis study is designed to determine the most effective anaesthetic method for same-day discharge after primary TKA and THA. With increasing outpatient surgeries, this study will be helpful for optimisation of outpatient processes.

trial registrationEU CT/CTIS: 2024-520127-89-00. CLINICALTRIALS: gov: NCT07334132.

Indexed as

Ambulatory Surgical ProceduresAnesthesia, GeneralAnesthesia, SpinalArthroplasty, Replacement, HipArthroplasty, Replacement, KneeEquivalence Trials as TopicHumansMulticenter Studies as TopicPragmatic Clinical Trials as TopicRandomized Controlled Trials as Topic

Identifiers

PMID42297351
PMCPMC13268700

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.